IL1B and oral lichen planus: Abboud CS et al. (2021) found no modulation in serum and salivary levels of IL-1β, -4, -6, -10, 17A, and TNF-α in OLP patients after PBM, although significant improvement in pain and clinical performance was achieved [3].